Considering the role of health economics in pyoderma gangrenosum and other dermatology research
Research output: Contribution to journal › Article › peer-review
Electronic versions
DOI
Keywords
- Cost-Benefit Analysis, Cyclosporine, Dermatology, Humans, Prednisolone, Pyoderma Gangrenosum
Original language | English |
---|---|
Pages (from-to) | 1475-1476 |
Journal | British Journal of Dermatology |
Volume | 177 |
Issue number | 6 |
DOIs | |
Publication status | Published - Dec 2017 |